secwatch.observer — SEC 8-K summary
======================================

Issuer:     60 DEGREES PHARMACEUTICALS, INC. (SXTP)
CIK:        0001946563
Form:       8-K
Filed at:   2024-02-28T23:59:59+00:00
Accession:  0001213900-24-017634
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

60 Degrees Pharma receives Nasdaq bid price deficiency notice; 180-day cure period
--------------------------------------------------------------------------------

- Nasdaq notified SXTP that common stock failed to maintain $1.00 minimum bid price for 31 consecutive business days through Feb 27, 2024.
- Company has 180 calendar days, until August 26, 2024, to regain compliance with the Bid Price Rule.
- If non-compliant by Aug 26, Company may be eligible for additional 180-day period if it meets other listing standards.
- Company is evaluating options; there is no immediate effect on listing of SXTP or SXTPW on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1946563/000121390024017634/0001213900-24-017634-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1946563/000121390024017634/ea0200827-8k_60degree.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-017634

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer